Celon Pharma improves financial results in 2018

Biopharmaceutical company Celon Pharma recorded PLN 29.7 million of net unit profit in 2018 as compared to PLN 25.62 million profit a year earlier, the company said. Operating profit amounted to PLN 35.61 million as compared to PLN 25.99 million profit a year earlier. Revenues from sales reached PLN 125.25 million in 2018 compared to PLN 107.12 million in 2017.

“The export has grown, reaching 24 percent at the end of the year, across all products ... We expect further product registrations in the following months, including on the French and Spanish market,” Bogdan Manowski, Celon Pharma’s board member, said. (ISBnews)